Assessing the Characteristics and Economic Burden of Febrile Neutropenia Associated With Antineoplastic Therapy at a Comprehensive Cancer Center

Key Points

• Assess the economic burden of febrile neutropenia associated with antineoplastic therapy in cancer patients.
• Conducted a retrospective analysis using hospitalization data.
• Focused on patients undergoing antineoplastic therapy for hematological malignancies.
• Evaluated the economic impact in terms of hospitalization costs.
• Hospitalization due to febrile neutropenia resulted in significant economic costs.
• The burden was particularly high among patients with hematological malignancies.
• Highlighting a need for effective preventive strategies to reduce hospitalization rates.